These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 354762)

  • 1. Immunologic detection of primary carcinoma of the pancreas.
    Taguchi K
    Can J Surg; 1978 Jul; 21(4):313-5. PubMed ID: 354762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte adherence inhibition assay to detect primary cancer of the pancreas.
    Taguchi K
    Surg Forum; 1977; 28():123-5. PubMed ID: 364711
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
    Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
    [No Abstract]   [Full Text] [Related]  

  • 5. Early diagnosis of cancers of colon, pancreas, stomach, and lung by automated tube leukocyte adherence inhibition assay.
    Tataryn DN; MacFarlane JK; Thomson DM
    Surg Forum; 1978; 29():130-2. PubMed ID: 401404
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specific immunity in patients with carcinoma of the pancreas. Preliminary report].
    Mester M; Zuliani A; Scheinberg MA; Machado MC
    Rev Hosp Clin Fac Med Sao Paulo; 1983 Jun; 38(3):107-10. PubMed ID: 6364296
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer.
    Russo AJ; Douglass HO; Leveson SH; Howell JH; Holyoke ED; Harvey SR; Chu TM; Goldrosen MH
    Cancer Res; 1978 Jul; 38(7):2023-9. PubMed ID: 77724
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The L.A.I. test and tumor markers (Ca 19-9 and TPA) in the diagnosis of pancreatic carcinoma].
    Meduri F; Bizzarini M; Diana F; Merenda R; Gerunda GE; Doni MG; Maffei Faccioli A
    Minerva Chir; 1989 Aug; 44(15-16):1777-81. PubMed ID: 2682370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for colorectal neoplasms].
    Shani A; Rozen P; Fink A; Bass D; Levy E; Fireman Z; Gottesfeld F; Baker S; Fraizer D; Bentwich Z
    Harefuah; 1990 Jan; 118(2):66-70. PubMed ID: 2179072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukocyte adhesion inhibition to glass (LAI test) and early diagnosis of pancreatic carcinoma].
    Meduri F; Bizzarini M; Diana F; Gerunda G; Maffei-Faccioli A
    Minerva Chir; 1986 Aug; 41(15-16):1283-8. PubMed ID: 3774173
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
    Goldrosen MH; Howell JH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
    Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
    Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
    Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
    Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
    Tannenbaum H; Wild J
    Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
    Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
    Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.